Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
15
Bearish filings
60
Named actors
30
Disclosed $ (bull / bear)
$0 / $16.8M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-16 | Chief Financial Officer Sullivan Christopher Ryan | sold | $202K | SEC ↗ |
| 2026-09-10 | Chief Financial Officer Sullivan Christopher Ryan | sold | $179K | SEC ↗ |
| 2026-08-28 | Chief Medical Officer Doyle Mittie | sold | $14K | SEC ↗ |
| 2026-08-18 | Chief Financial Officer Sullivan Christopher Ryan | sold | $622K | SEC ↗ |
| 2026-08-18 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) CHRISTOPHER RYAN SULLIVAN | filed notice to sell | $622K | SEC ↗ |
50 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-17 | Chief Financial Officer Sullivan Christopher Ryan | sold | $75K | SEC ↗ |
| 2026-08-17 | Chief Financial Officer Sullivan Christopher Ryan | sold | $753K | SEC ↗ |
| 2026-08-17 | Chief Medical Officer Doyle Mittie | sold | $20K | SEC ↗ |
| 2026-08-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) CHRISTOPHER RYAN SULLIVAN | filed notice to sell | $75K | SEC ↗ |
| 2026-08-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) CHRISTOPHER RYAN SULLIVAN | filed notice to sell | $1.4M | SEC ↗ |
| 2026-08-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MITTIE DOYLE | filed notice to sell | $99K | SEC ↗ |
| 2026-08-14 | 5%+ holder (13G) — increased stake Deep Track Capital, LP | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-11 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JENNIFER RILEY | filed notice to sell | $52K | SEC ↗ |
| 2026-08-11 | Chief Strategy Officer Riley Jennifer | sold | $52K | SEC ↗ |
| 2026-08-10 | Chief Medical Officer Doyle Mittie | sold | $14K | SEC ↗ |
| 2026-08-10 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MITTIE DOYLE | filed notice to sell | $12K | SEC ↗ |
| 2026-07-27 | 5%+ holder (13G) BlackRock, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-30 | Chief Medical Officer Doyle Mittie | sold | $93K | SEC ↗ |
| 2026-06-23 | Chief Medical Officer Doyle Mittie | sold | $26K | SEC ↗ |
| 2026-06-18 | 5%+ holder (13G) Commodore Capital LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-02 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) JONATHAN GOLDMAN | filed notice to sell | $616K | SEC ↗ |
| 2026-05-29 | 5%+ holder (13G) Deep Track Capital, LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-28 | Chief Medical Officer Doyle Mittie | sold | $11K | SEC ↗ |
| 2026-05-26 | 5%+ holder (13G) Point72 Asset Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) T. Rowe Price Investment Management, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |